In recent years, the development of more effective drugs has provided a better prognosis
and an increase in life expectancy for patients at all-stages of cancer. On the other hand, the …

Along with the remarkable progress registered in oncological treatment that led to increased
survival of cancer patients, treatment-related comorbidities have also become an issue for …

As medicine advances to employ sophisticated anticancer agents to treat a vast array of
oncological conditions, it is worth considering side effects associated with several …

Chemotherapy is a main treatment for cancer, and it benefits patients by controlling cancer
relapse and metastasis, thereby leading to an increase in the overall survival rate. However …

Tremendous strides have been made in the treatment of various oncological diseases such
that patients are surviving longer and are having better quality of life. However, the success …

Rapid advancements in oncological treatments over the past few decades have led to a
significant improvement in cancer outcomes. Chemotherapeutic agents play a pivotal role in …

Cardiovascular toxicity caused by cancer therapy is a challenging area which needs
thorough evaluation and research. Numerous studies, meta-analyses and reviews have …

Background. Cardiotoxicity caused by chemotherapy, with its diverse early and late
presentations, can hamper potentially curative or palliative treatments. The drugs most often …

Chemotherapy and targeted therapies have significantly improved the prognosis of
oncology patients. However, these antineoplastic treatments may also induce adverse …

Cardiotoxic effects of chemotherapy and targeted drugs are ubiquitous and challenging in
the field of oncology therapeutics. The broad spectrum of toxicities ranging from ischemic …